Σφακιανάκης Αλέξανδρος
ΩτοΡινοΛαρυγγολόγος
Αναπαύσεως 5 Άγιος Νικόλαος
Κρήτη 72100
00302841026182
00306932607174
alsfakia@gmail.com

Αρχειοθήκη ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader

Η λίστα ιστολογίων μου

Σάββατο 8 Δεκεμβρίου 2018

Non Surgical Rhinoplasty: Nasal Grid Analysis and Nasal Injecting protocol

Objective: Non-surgical rhinoplasty using injectable fillers, in contrast to traditional but more invasive surgery, offers low morbidity, improved skin quality and texture, cost-effectiveness and quick recovery. The aim of this study was to provide a valid and customized protocol for injecting the nose with the aid of a nasal grid to achieve constant attractive results. Materials and Methods: From January 2015 and October 2018 150 consecutive patients entered the non-surgical rhinoplasty trial. The mean age of the patients was 36 years old (range 16-60). The patients were divided into two arms: primary nasal defects (no previous surgery, n=109) and secondary nasal defects (previous surgery, n=41). The primary defect group included 43 male patients and 66 females and the second one 14 males and 27 females. Within each arm, patients were stratified into 3 age group tiers: 45 years old. Results: The grid became the reference for quantity and sequence of injection records, with reproducibility potential for future injections. Overall rate of complication was 1.82%. with a VAS 1 to 10 was implemented (10 being the most accurate correction). 98.350% of patients scored 8 to 10, 0.825% 6-8, 0.825% scored below 6. Discussion: Fillers can be either alternatives or complementary to plastic surgery. Today's non-surgical approach to rhinoplasty offers more choice to patients. Non-surgical rhinoplasty, with its avoidance of general anesthesia, splints, swelling and bruising represents a distinct advantage, allowing the patient to return to work as quickly as same or next day. Financial Disclosure Statement: None of the authors has a financial interest in any of the products, devices, or drugs mentioned in this manuscript. Professor Dario Bertossi is Consultant and speaker for Allergan S.p.A. Acknowledgements: None Corresponding Author: Prof. Dario Bertossi, MD, Department of Maxillo Facial Surgery, University of Verona "G.B. Rossi Hospital", Piazzale L.A. Scuro 10 , 37134 Verona, Italy. e-mail: dario.bertossi@univr.it, Tel: 00390458124251, Fax: 00390458127437 ©2018American Society of Plastic Surgeons

https://ift.tt/2SyrDjq

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αρχειοθήκη ιστολογίου